FLT4 and lymphedema: NRP2 is highly expressed during ischemia/hypoxia conditions.48–50 Somatic alterations in NRP2, Fms-related tyrosine kinase 4, and VEGFC are typically observed in breast cancer patients51,52 and these alterations exhibit a strong tendency to facilitate secondary lymphedema.53–55